[eDisclosure Notice] Hanwha Solutions Announces Share Buyback Until October 17 (Morning Summary)

[Asia Economy Reporter Lee Jung-yoon] Hanwha Solutions announced on the 26th that it will conduct a public tender offer for 1,362,800 common shares and 10,500 preferred shares until October 17. The purchase price is 51,000 KRW per common share and 47,669 KRW per preferred share.

The company stated, "Hanwha Solutions, as both the tender offeror and the target company, plans to spin off its lightweight composite materials business division and solar materials business division. Accordingly, considering the Financial Services Commission's 'Measures to Enhance the Rights of General Shareholders Regarding the Listing of Subsidiaries through Physical Spin-offs' and the intent to grant stock purchase rights upon spin-offs, we intend to conduct this tender offer to protect shareholder rights."

▲ Hanwha Solutions = Conducting a public tender offer for 1,362,800 common shares and 10,500 preferred shares

▲ Kolon Global = Awarded a construction contract worth 65.365 billion KRW for the Busan Daeyeon Street Housing Maintenance Project

▲ SK Biopharm = Signed a pharmaceutical supply contract worth 23.9283 billion KRW with its subsidiary SK Life Science

▲ Inometry = Signed a contract to supply X-ray inspection equipment for secondary batteries worth 5.75945 billion KRW

▲ Curacle = Received FDA IND approval for Phase 2a clinical trial of diabetic macular edema treatment (CU06) in the U.S.

This content was produced with the assistance of AI translation services.